BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10548443)

  • 1. A unique drug treatment program for pregnant and postpartum substance-using women in New York City: results of a pilot project, 1990-1995.
    McMurtrie C; Rosenberg KD; Kerker BD; Kan J; Graham EH
    Am J Drug Alcohol Abuse; 1999 Nov; 25(4):701-13. PubMed ID: 10548443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample.
    Richardson GA; Hamel SC; Goldschmidt L; Day NL
    Pediatrics; 1999 Aug; 104(2):e18. PubMed ID: 10429136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
    Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
    Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse perinatal outcome in parturients who use crack cocaine.
    Sprauve ME; Lindsay MK; Herbert S; Graves W
    Obstet Gynecol; 1997 May; 89(5 Pt 1):674-8. PubMed ID: 9166299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of intrauterine cocaine exposure in newborns.
    Bateman DA; Ng SK; Hansen CA; Heagarty MC
    Am J Public Health; 1993 Feb; 83(2):190-3. PubMed ID: 8427321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison study of treated and untreated pregnant and postpartum cocaine-abusing women.
    Smith IE; Dent DZ; Coles CD; Falek A
    J Subst Abuse Treat; 1992; 9(4):343-8. PubMed ID: 1336070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case management of pregnant and parenting female crack and polydrug abusers.
    Lanehart RE; Clark HB; Kratochvil D; Rollings JP; Fidora AF
    J Subst Abuse; 1994; 6(4):441-8. PubMed ID: 7780302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the success of substance abuse prevention and treatment programs for pregnant and postpartum women and their infants.
    Lieberman LD
    Womens Health Issues; 1998; 8(4):218-29. PubMed ID: 9702124
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of substance use outcomes in demonstration projects for pregnant and postpartum women and their infants: findings from a quasi-experiment.
    Eisen M; Keyser-Smith J; Dampeer J; Sambrano S
    Addict Behav; 2000; 25(1):123-9. PubMed ID: 10708327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prenatal cocaine/crack and other drug exposure on electroencephalographic sleep studies at birth and one year.
    Scher MS; Richardson GA; Day NL
    Pediatrics; 2000 Jan; 105(1 Pt 1):39-48. PubMed ID: 10617702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of substance abuse during pregnancy and infant outcome.
    Little BB; Snell LM; Van Beveren TT; Crowell RB; Trayler S; Johnston WL
    Am J Perinatol; 2003 Jul; 20(5):255-62. PubMed ID: 13680509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of substance abuse prevention and treatment approaches in urban, multicultural settings: the Center for Substance Abuse Prevention programs for pregnant and postpartum women and their infants.
    Lieberman LD
    Womens Health Issues; 1998; 8(4):208-17. PubMed ID: 9702123
    [No Abstract]   [Full Text] [Related]  

  • 15. Multi-service prevention programs for pregnant and parenting women with substance use and multiple vulnerabilities: Program structure and clients' perspectives on wraparound programming.
    Rutman D; Hubberstey C; Poole N; Schmidt RA; Van Bibber M
    BMC Pregnancy Childbirth; 2020 Aug; 20(1):441. PubMed ID: 32746789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine use during pregnancy and intrauterine growth retardation: new insights based on maternal hair tests.
    Kuhn L; Kline J; Ng S; Levin B; Susser M
    Am J Epidemiol; 2000 Jul; 152(2):112-9. PubMed ID: 10909947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment retention and birth outcomes of crack users enrolled in a substance abuse treatment program for pregnant women.
    Fiocchi FF; Kingree JB
    J Subst Abuse Treat; 2001 Mar; 20(2):137-42. PubMed ID: 11306216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydrug-using adolescent mothers and their infants receiving early intervention.
    Field TM; Scafidi F; Pickens J; Prodromidis M; Pelaez-Nogueras M; Torquati J; Wilcox H; Malphurs J; Schanberg S; Kuhn C
    Adolescence; 1998; 33(129):117-43. PubMed ID: 9583666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study.
    van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
    Drug Alcohol Depend; 2010 Jun; 109(1-3):243-7. PubMed ID: 20171023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal patterns of cocaine use in pregnancy. Perinatal outcome.
    Chasnoff IJ; Griffith DR; MacGregor S; Dirkes K; Burns KA
    JAMA; 1989 Mar 24-31; 261(12):1741-4. PubMed ID: 2918671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.